Skip to content
ppharmaranks
Menu

Best Monoamine Oxidase Inhibitor for depressive disorder

3 Monoamine Oxidase Inhibitor drugs used for depressive disorder, ranked by our independent rating. Compare them with all treatments for depressive disorder or the full Monoamine Oxidase Inhibitor class. Not medical advice — always consult a professional.

Quick answer: Of the 3 monoamine oxidase inhibitor drugs we rate for depressive disorder, all are available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for depressive disorder; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Get treated for depressive disorder online

Licensed online providers — consult & get prescribed if eligible.

Advertising disclosure: We may earn a commission, at no extra cost to you. This never affects our ratings. Details

Top monoamine oxidase inhibitor for depressive disorder: 1. Emsam · 2. Nardil · 3. Zelapar

Best-rated Monoamine Oxidase Inhibitor for depressive disorder, ranked by pharmaranks score
#DrugRatingPharmacy pays
1Not yet rated$20View →
2Not yet rated$18View →
3Not yet rated$20View →

Full ranking · 3 drugs

Frequently asked

What is the best monoamine oxidase inhibitor for depressive disorder?
Ratings are based on FDA regulatory recall-safety data — always consult a professional.
Which monoamine oxidase inhibitor drugs treat depressive disorder?
pharmaranks lists 3 Monoamine Oxidase Inhibitor products used for depressive disorder, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.